Reporting Organization: | WHO - World Health Organization |
---|---|
Total Budget ($CAD): | $ 1,000,000 |
Timeframe: | March 29, 2010 - March 31, 2013 |
Status: | Completion |
Contact Information: | Unspecified |
WHO - World Health Organization
Unspecified
Sub-Saharan Africa - $ 617,000.00 (61.70%) | |
|
|
Southeast Asia - $ 100,000.00 (10.00%) | |
|
|
North Africa - $ 83,000.00 (8.30%) | |
|
|
South Asia - $ 82,000.00 (8.20%) | |
|
|
East Asia - $ 73,000.00 (7.30%) | |
|
|
Central Asia - $ 45,000.00 (4.50%) | |
|
Health Systems, Training & Infrastructure (90 %) | |
|
|
Primary Health Care (10 %) | |
|
This grant is part of CIDA’s continued support to the Canadian International Immunization Initiative (CIII). CIII aims to increase immunization coverage rates and lower morbidity and mortality from vaccine-preventable diseases. Phase III focuses on increasing equitable access to vaccinations by targeting districts with low coverage rates and by reaching the most vulnerable and underserved groups in these districts. UNICEF and the World Health Organization (WHO) jointly implement the multilateral component of CIII. This grant supports WHO activities. WHO provides technical expertise to low-income countries to strengthen routine immunization services. With CIII funding, WHO’s support guides countries in adopting best practices that increase immunization rates at district level. Immunization currently prevents approximately 2.5 million child deaths every year in all age groups. Basic immunizations are a universally recommended, cost-effective, public health priority. Canada’s support for immunization initiatives is in line with the Millennium Development Goal (MDG) of reducing the death rate among children under the age of five by two-thirds by 2015.
Gender and age: | Under-5 children |
---|---|
Total Direct Population: | Unspecified |
Unspecified
Return to topUnspecified
As of January 2012, results have been achieved in 26 countries, primarily in Africa. For example, in Mozambique, the number of children who received the diphtheria-tetanus-pertussis vaccine rose from 67% to 85% in 28 priority districts.